
An analysis of top ERP systems for the pharmaceutical sector, evaluated on regulatory compliance (21 CFR Part 11), batch traceability, and serialization. Updated for 2025–2026 with DSCSA enforcement timelines, AI/Copilot capabilities, and latest platform releases.

